Dr. Cipriani is a surgical pathologist with a clinical subspecialty focus in Head & Neck, Thyroid, and Bone & Soft Tissue Pathology. Her diagnostic and research interests include neoplastic diseases of the thyroid gland, salivary glands, and upper aerodigestive tract. She also has an interest in Anatomic Pathologic Informatics, including web design, digital imaging, and virtual slides.
Co-Director of Surgical Pathology, The University of Chicago
Director of Anatomic Pathology Informatics, The University of Chicago
Treasurer, North American Society of Head & Neck Pathology
Massachusetts General Hospital
Boston, MA
Fellowship - Head & Neck and Bone & Soft Tissue Pathology
2013
The University of Chicago
Chicago, IL
Residency - Anatomic & Clinical Pathology
2012
The University of Chicago Pritzker School of Medicine
Chicago, IL
MD - Medicine
2008
The University of Illinois at Chicago
Chicago, IL
MS - Medical Illustration / Biomedical Visualization
2004
The University of Chicago
Chicago, IL
AB - Biological Sciences & Visual Arts
2002
Pleomorphic Adenoma with Epithelial Atypia, Apocrine Metaplasia, and/or In situ/Intracapsular Salivary Duct Carcinoma Are Indolent Lesions with Good Prognosis: A Proposal for Unified Nomenclature and Clinical Observation.
Pleomorphic Adenoma with Epithelial Atypia, Apocrine Metaplasia, and/or In situ/Intracapsular Salivary Duct Carcinoma Are Indolent Lesions with Good Prognosis: A Proposal for Unified Nomenclature and Clinical Observation. Head Neck Pathol. 2025 Sep 12; 19(1):109.
PMID: 40938457
Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features and CREB3L2::PPAR? Fusion.
Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features and CREB3L2::PPAR? Fusion. Head Neck Pathol. 2025 Aug 21; 19(1):105.
PMID: 40839045
Building digital histology models of transcriptional tumor programs with generative deep learning for pathology-based precision medicine.
Building digital histology models of transcriptional tumor programs with generative deep learning for pathology-based precision medicine. Genome Med. 2025 Aug 07; 17(1):87.
PMID: 40775734
Revisionist history uncovers a simplified molecular-based classification of differentiated thyroid cancer.
Revisionist history uncovers a simplified molecular-based classification of differentiated thyroid cancer. J Pathol. 2025 Oct; 267(2):130-141.
PMID: 40762994
Corrigendum to "Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas". [Oral Oncol. 163 (2025) 107207].
Corrigendum to "Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas". [Oral Oncol. 163 (2025) 107207]. Oral Oncol. 2025 Oct; 169:107510.
PMID: 40721367
Risk of malignancy associated with indeterminate categories in the Milan System for reporting pediatric salivary gland cytopathology: a multi-institutional study.
Risk of malignancy associated with indeterminate categories in the Milan System for reporting pediatric salivary gland cytopathology: a multi-institutional study. J Am Soc Cytopathol. 2026 Jan-Feb; 15(1):39-45.
PMID: 40781025
Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized Clinical Trial.
Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized Clinical Trial. JAMA Oncol. 2025 May 01; 11(5):492-501.
PMID: 40048190
Prevalence and Clinical Impact of BRAF p.V600E Mutation in Papillary Thyroid Carcinoma.
Prevalence and Clinical Impact of BRAF p.V600E Mutation in Papillary Thyroid Carcinoma. Endocr Pathol. 2025 Apr 16; 36(1):13.
PMID: 40237893
Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas.
Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas. Oral Oncol. 2025 Apr; 163:107207.
PMID: 40043423
DEK :: AFF2 Fusion Sinonasal and Skull Base Nonkeratinizing Squamous Cell Carcinoma : A Clinical Outcome Study Compared With Conventional Sinonasal Squamous Cell Carcinoma.
DEK :: AFF2 Fusion Sinonasal and Skull Base Nonkeratinizing Squamous Cell Carcinoma : A Clinical Outcome Study Compared With Conventional Sinonasal Squamous Cell Carcinoma. Am J Surg Pathol. 2025 Feb 01; 49(2):130-137.
PMID: 39719672